TET enzymes regulate skeletal development through increasing chromatin accessibility of RUNX2 target genes.
Lijun WangXiuling YouDengfeng RuanRui ShaoHai-Qiang DaiWeiliang ShenGuo-Liang XuWanlu LiuWeiguo ZouPublished in: Nature communications (2022)
The Ten-eleven translocation (TET) family of dioxygenases mediate cytosine demethylation by catalyzing the oxidation of 5-methylcytosine (5mC). TET-mediated DNA demethylation controls the proper differentiation of embryonic stem cells and TET members display functional redundancy during early gastrulation. However, it is unclear if TET proteins have functional significance in mammalian skeletal development. Here, we report that Tet genes deficiency in mesoderm mesenchymal stem cells results in severe defects of bone development. The existence of any single Tet gene allele can support early bone formation, suggesting a functional redundancy of TET proteins. Integrative analyses of RNA-seq, Whole Genome Bisulfite Sequencing (WGBS), 5hmC-Seal and Assay for Transposase-Accessible Chromatin (ATAC-seq) demonstrate that TET-mediated demethylation increases the chromatin accessibility of target genes by RUNX2 and facilities RUNX2-regulated transcription. In addition, TET proteins interact with RUNX2 through their catalytic domain to regulate cytosine methylation around RUNX2 binding region. The catalytic domain is indispensable for TET enzymes to regulate RUNX2 transcription activity on its target genes and to regulate bone development. These results demonstrate that TET enzymes function to regulate RUNX2 activity and maintain skeletal homeostasis.
Keyphrases
- transcription factor
- genome wide
- genome wide identification
- rna seq
- single cell
- gene expression
- dna methylation
- dna damage
- copy number
- bone mineral density
- bone marrow
- high throughput
- nitric oxide
- genome wide analysis
- hydrogen peroxide
- body composition
- soft tissue
- smoking cessation
- postmenopausal women
- cell therapy
- nucleic acid